PMID- 21251414
OWN - NLM
STAT- MEDLINE
DCOM- 20110607
LR  - 20220310
IS  - 1488-2310 (Electronic)
IS  - 0008-428X (Print)
IS  - 0008-428X (Linking)
VI  - 54
IP  - 2
DP  - 2011 Apr
TI  - Early results of a Canadian laparoscopic sleeve gastrectomy experience.
PG  - 138-43
LID - 10.1503/cjs.041209 [doi]
AB  - BACKGROUND: Sleeve gastrectomy (SG) is a relatively new bariatric procedure with 
      a number of advantages compared with Roux-en-Y gastric bypass. However, SG also 
      has a number of disadvantages and associated risks. We sought to examine 
      perioperative complications and outcomes of laparoscopic SG (LSG) in a single 
      major Canadian bariatric surgery centre (Victoria, BC). METHODS: Since June 2008, 
      LSG has been performed at our centre and we reviewed the cases of all patients. 
      We conducted a retrospective chart review in April 2010. RESULTS: Thirty-four 
      patients had LSG, and none was lost to follow-up. Indications for LSG over other 
      bariatric procedures were patient preference (n=28), severe obesity with a body 
      mass index (BMI) greater than 60 kg/m(2) (n=5) and severe upper abdominal 
      adhesions (n=1). All but 1 of the cohort were women, and the average age was 48 
      (standard deviation [SD] 11) years. Preoperatively, the average BMI was 50.3 (SD 
      7.7) kg/m(2). Preoperative obesity-related comorbidity rates were 56% (n=19) for 
      type 2 diabetes mellitus (T2DM), 50% (n=17) for hypertension, 32% (n=11) for dys 
      lipidemia, 62% (n=21) for obstructive sleep apnea (OSA), 62% (n=21) for knee 
      and/or hip pain and 44% (n=15) for depression and/or anxiety. The mean duration 
      of surgery was 74 (SD 21) minutes. There were 2 major perioperative 
      complications: 1 staple line leak and 1 staple line hemorrhage. The median stay 
      in hospital was 1 day. Postoperative upper gastrointestinal imaging studies were 
      conducted in 11 patients; 1 was positive for staple line leak. Histopathology on 
      the excised gastric segments revealed chronic helicobacter pylori gastritis in 2 
      patients and small gastrointestinal stromal tumours in 1 patient. The mean 
      postoperative follow-up interval was 10 months. Weight loss averaged 27.4 (SD 
      9.0) kg. Overall weight loss was 3.3 (SD 1.8) kg/month. Resolution occurred in 
      74% of patients with T2DM, 53% with hypertension, 45% with dyslipidemia, 76% with 
      OSA, 38% with joint pain and 20% with depression/anxiety. Overall satisfaction 
      was rated as excellent by 68% of patients, good by 29% and poor by 3% of 
      patients. CONCLUSION: Preliminary analysis of our experience with LSG indicates 
      that this is an effective and safe procedure for the treatment of obesity.
CI  - (c) 2011 Canadian Medical Association
FAU - Behrens, Carola
AU  - Behrens C
AD  - Department of Radiology, University of British Columbia, Vancouver, BC, Canada.
FAU - Tang, Bao Q
AU  - Tang BQ
FAU - Amson, Bradley J
AU  - Amson BJ
LA  - eng
PT  - Journal Article
PL  - Canada
TA  - Can J Surg
JT  - Canadian journal of surgery. Journal canadien de chirurgie
JID - 0372715
SB  - IM
MH  - Adult
MH  - Aged
MH  - Canada
MH  - Comorbidity
MH  - Diabetes Mellitus/epidemiology
MH  - Female
MH  - Gastrectomy/adverse effects/*methods
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Obesity, Morbid/epidemiology/surgery
MH  - Retrospective Studies
MH  - Treatment Outcome
MH  - Weight Loss
PMC - PMC3116697
EDAT- 2011/01/22 06:00
MHDA- 2011/06/08 06:00
PMCR- 2011/04/01
CRDT- 2011/01/22 06:00
PHST- 2011/01/22 06:00 [entrez]
PHST- 2011/01/22 06:00 [pubmed]
PHST- 2011/06/08 06:00 [medline]
PHST- 2011/04/01 00:00 [pmc-release]
AID - 10.1503/cjs.041209 [pii]
AID - 0540138 [pii]
AID - 10.1503/cjs.041209 [doi]
PST - ppublish
SO  - Can J Surg. 2011 Apr;54(2):138-43. doi: 10.1503/cjs.041209.